Report Describes iTRAQ of Lung & Breast Cancer Serum Samples For AlbuVoid™ LC-MS On Bead Product

Application Report on AlbuVoid™ LC-MS On-Bead Differential Expression of Cancer Sera Proteins Using Quantitative (iTRAQ) Proteomics
By: Biotech Support Group
 
 
biotechsupportgroup_AlbuVoid™_BeadProteomesiTRAQ
biotechsupportgroup_AlbuVoid_BeadProteomesiTRAQ
MONMOUTH JUNCTION, N.J. - May 13, 2015 - PRLog -- MONMOUTH JUNCTION, NJ, May 13, 2015 -- Biotech Support Group reports on a new application report describing a quantitative study of cancer sera using a new product for combining albumin depletion, low abundance enrichment and on-bead digestion. The product is an extension of the AlbuVoid™ product line for improved digestion efficiency of serum proteins first enriched with AlbuVoid™.  The application report is entitled:

AlbuVoid™ LC-MS On-Bead – Differential Expression of Cancer Sera Proteins Using Quantitative (iTRAQ) Proteomics (http://biotechsupportgroup.com/sites/default/files/AlbuVoid%20Serum%20iTRAQ%20Application%20Report.Rev%20051315%20v2.pdf)

The report describes the differential analysis of breast cancer, lung cancer and normal pooled serum samples. iTRAQ peptide labeling was used to track the relative abundances of 201 total proteins, 21 of which were observed to be differentially expressed in one or both cancer samples.

The combined method described in the report shows how low abundance enrichment integrated with on-bead digestion offers many workflow advantages:

Unique chemically derived beads, AlbuVoid™ is a consumable, one-time use product with no potential for cross-contamination or reduced. performance upon regeneration.
Species agnostic; human, rat, mouse, goat, sheep, porcine and bovine sera have been tested.
No in-gel digests, no solution digests, no C18 desalting, more consistent, reproducible results.

The report can be downloaded from the company website at:

www.biotechsupportgroup.com/sites/default/files/AlbuVoid%20LC-MS%20On-Bead%20Differential%20Expression%20of%20Lung%20&%20Breast%20Cancer%20Sera%20Proteins%20Using%20Quantitative%20(iTRAQ)%20Proteomics%20Application%20Report.pdf

“I am very pleased that now with our new AlbuVoid™ product for efficient on-bead methods, digestions of serum samples have been shown to be suitable for quantitative proteomics. Convincingly, several of the proteins we differentially observed have also been cited previously, but were observed only after much more onerous workflows.” states Swapan Roy, Ph.D., President and Founder of Biotech Support Group.

About Biotech Support Group LLC
Biotech Support Group LLC is a leading provider of proteomic, metabolomic and genomic sample preparation and enrichment products and services. It’s principal products include: AlbuVoid™ & AlbuSorb™ for albumin depletion, Cleanascite™ for lipid adsorption and clarification, HemogloBind™ & HemoVoid™ for hemoglobin removal, NuGel™ for functional & chemical proteomics, and ProCipitate™ for nucleic acid isolation. For more information, go to http://www.biotechsupportgroup.com

Contact:
Dr. Swapan Roy & Matthew Kuruc
Biotech Support Group LLC
1 Deer Park Drive, Suite M
Monmouth Junction NJ 08852
732-274-2866 Worldwide
800-935-0628 North America
sales@biotechsupportgroup.com
http://www.biotechsupportgroup.com

Contact
Biotech Support Group
***@biotechsupportgroup.com
End
Source:Biotech Support Group
Email:***@biotechsupportgroup.com Email Verified
Tags:Protein profiling, Lung Cancer, Breast Cancer, Itraq, Cancer Proteomics
Industry:Biotech, Medical
Location:Monmouth Junction - New Jersey - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Biotech Support Group LLC News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share